For the Inventor, By the Inventor

Enter assignee name

Framingham, MA, United States of America

Gtc Biotherapeutics, Inc.

USPTO Granted Patents = 11

EPO Patents = 1

Forward Citations = 109

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Harry M Meade (8 out of 22 patents)

Edward S Cole (2 out of 6 patents)

Li How Chen (2 out of 3 patents)

4. Li-How Chen (1 out of 4 patents)

5. Scott P Fulton (1 out of 7 patents)

6. Daniel Pollock (1 out of 3 patents)

7. Katherine Gordon (1 out of 3 patents)

8. Suzanne Groet (1 out of 4 patents)

9. Paul DiTullio (1 out of 4 patents)

10. Sinikka Uotila (1 out of 5 patents)

11. Kalevi Visuri (1 out of 5 patents)

12. Geoffrey F Cox (1 out of 1 patent)

13. Mark A Perreault (1 out of 5 patents)

14. Ian Krane (1 out of 3 patents)

15. Michael Young (1 out of 2 patents)

11 patents: Sort by Forward Citations

1. 8173860 - Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion (2012-05-08),

2. 7928064 - Transgenically produced antithrombin III (2011-04-19),

3. 7632980 - Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems (2009-12-15),

4. 7550263 - Method for the production of fusion proteins in transgenic mammal milk (2009-06-23),

5. 7531632 - Clarification of transgenic milk using depth filtration (2009-05-12),

6. 7501553 - Non-human transgenic mammal comprising a modified MSP-1 nucleic acid (2009-03-10),

7. 7354594 - Merozoite surface protein 1 lacking glycosylation sites (2008-04-08),

8. 7101971 - Erythropoietin analog-human serum albumin fusion (2006-09-05),

9. 7087719 - Method for the crystallization of human serum albumin (2006-08-08),

10. 7045676 - Transgenic animals secreting proteins into milk (2006-05-16),

11. 7019193 - Treatments using transgenic goat produced antithrombin III (2006-03-28),

GTC Biotherapeutics, Inc. is a leading biopharmaceutical company specializing in the development and production of therapeutic proteins. With a focus on the field of human therapeutics, GTC Biotherapeutics is dedicated to developing innovative treatments for various diseases and medical conditions. Leveraging their expertise in biotechnology and genetic engineering, the company utilizes novel approaches to create biotherapeutic products with enhanced safety and efficacy. GTC Biotherapeutics is committed to advancing the standards of care and improving the lives of patients worldwide. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#21 in Framingham, MA

#1,615 in Massachusetts

#26,744 in US

#50,231 in the World

Framingham, MA, United States of America

Gtc Biotherapeutics, Inc.

Forward Citations = 109

17 inventors:

Harry M Meade (8 out of 22 patents)

Edward S Cole (2 out of 6 patents)

Li How Chen (2 out of 3 patents)

4. Li-How Chen (1 out of 4 patents)

5. Scott P Fulton (1 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…